Elekta AB (publ) (EKTAY)

Market Cap	2.04B
Revenue (ttm)	1.83B
Net Income (ttm)	28.04M
Shares Out	n/a
EPS (ttm)	0.07
PE Ratio	72.88
Forward PE	14.40
Dividend	0.14 (2.64%)
Ex-Dividend Date	Sep 8, 2025

Volume	1,286
Average Volume	4,458
Open	5.30
Previous Close	5.31
Day's Range	5.20 - 5.30
52-Week Range	4.36 - 7.13
Beta	1.01
RSI	65.47
Earnings Date	Aug 28, 2025

About Elekta AB

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as wel...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1972
• Employees: 4,556
• Stock Exchange: OTCMKTS
• Ticker Symbol: EKTAY

Financial Performance

In 2025, Elekta AB's revenue was 18.02 billion, a decrease of -0.57% compared to the previous year's 18.12 billion. Earnings were 237.00 million, a decrease of -81.80%.

Financial numbers in SEK